Post-Traumatic Stress Disorder: Clinical Trials

19 trials for Post-Traumatic Stress Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed, 2 terminated, 2 unknown, 1 active not recruiting. 19 Phase 3, 7 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 319Completed 13, Terminated 2, Unknown 2, Active not recruiting 1, Withdrawn 1
Phase 27Completed 4, Unknown 2, Withdrawn 1

Follow Post-Traumatic Stress Disorder: new trials by email Literature Review of Post-Traumatic Stress Disorder trials Research Report on Post-Traumatic Stress Disorder

Trials (filtered) newest first · largest first

All 19 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
MDMA-assisted Massed Prolonged Exposure for PTSD
3,4 Methylenedioxymethamphetamine, Prolonged Exposure - Post-Traumatic Stress Disorder
Phase 3Active not recruitingHealing Breakthrough202024-10-252026-08-26
Study of the Safety and Efficacy of Nabiximols Oromucosal Spray Versus Placebo in Patients With Post-traumatic Stress Disorder
Nabiximols, Placebo - Post-Traumatic Stress Disorder
Phase 2 / Phase 3WithdrawnJazz Pharmaceuticals2021-02-012022-06-03
Using Reconsolidation Blockade to Treat Trauma Related Disorders After Paris Attacks: an Effectiveness Study
β-adrenergic blocker propranolol, Treatment as usual - Post-traumatic Stress Disorder
Phase 3CompletedAssistance Publique - Hôpitaux de Paris3642016-05-272023-03-22
Helping Children With Trauma
Trauma Systems Therapy (TST), Treatment as Usual (TAU) - Trauma, Post-Traumatic Stress Disorder
Phase 3TerminatedNYU Langone Health142016-02-012017-03-31
Effectiveness of PTSD Treatment For Suicidal and Multi-Diagnostic Clients
Dialectical Behavior Therapy, Dialectical Behavior Therapy Prolonged Exposure protocol - Post-traumatic Stress Disorder, Suicide
Phase 2 / Phase 3CompletedUniversity of Washington352016-02-012019-09-17
Brexpiprazole as an Adjunctive Treatment to Paroxetine or Sertraline in Adult Patients Suffering From Post-traumatic Stress Disorder (PTSD)
Placebo, Brexpiprazole - Post-traumatic Stress Disorder, PTSD
Phase 3TerminatedH. Lundbeck A/S4172013-12-012017-03-13
Intervention to Support the Reintegration of Former Combatants and Soldiers
NET for Forensic Offender Rehabilitation (FORNET): a variant of Narrative Exposure Therapy, Control group - Appetitive Aggression, Post-traumatic Stress Disorder
Phase 2 / Phase 3UnknownUniversity of Konstanz1002012-06-012013-07-30
Maximizing Treatment Outcome and Examining Sleep in Post-traumatic Stress Disorder (PTSD)
Prolonged Exposure, Exercise, Wellness Intervention - Post-Traumatic Stress Disorder
Phase 3CompletedSouthern Methodist University92010-09-012014-12-10
Maximizing Treatment Outcome in Post-Traumatic Stress Disorder (PTSD)
Prolonged Exposure, Exercise - Post-Traumatic Stress Disorder
Phase 3CompletedUniversity of Texas at Austin282010-09-012015-12-29
Comparison of Videoconference and Face-to-Face Delivery of Cognitive Processing Therapy for Posttraumatic Stress Disorder
Cognitive Processing Therapy (CPT) - Post-Traumatic Stress Disorder
Phase 3CompletedUniversity of Wisconsin, Madison902009-12-012015-10-02
Effectiveness of Cognitive Behavioral Couples Therapy for Post-traumatic Stress Disorder
Cognitive behavioral couples therapy for post-traumatic stress disorder (CBCT for PTSD) - Post-traumatic Stress Disorder
Phase 2 / Phase 3CompletedToronto Metropolitan University802008-08-012013-11-26
RCT of CBT Combined With D-Cycloserine for Treating PTSD
D-cycloserine, Cognitive-Behavioral Therapy - Post-Traumatic Stress Disorder
Phase 2 / Phase 3UnknownUniversité de Montréal202007-02-012007-03-27
Levetiracetam in Post-Traumatic Stress Disorder
levetiracetam, Placebo, Levetriracetam - Post-Traumatic Stress Disorder
Phase 2 / Phase 3CompletedDuke University162005-11-012014-07-21
KIDNET Versus Meditation/Relaxation - a Dissemination RCTT for Children in Sri Lanka Traumatized by the War and the Tsunami
KIDNET, Meditation-Relaxation - Post-Traumatic Stress Disorder
Phase 3CompletedUniversity of Konstanz312005-01-012009-01-12
Use of Quetiapine as an Add on Therapy in the Treatment of Post Traumatic Stress Disorder
Quetiapine Fumarate, quetiapine fumarate placebo - Post-Traumatic Stress Disorder
Phase 3CompletedAstraZeneca902004-12-012010-12-09
Comparison of Two Treatments for Post-Traumatic Stress Disorder
Sertraline, Cognitive behavioral therapy (CBT) - Post-Traumatic Stress Disorder
Phase 3CompletedCase Western Reserve University2002004-09-012022-05-24
The Trauma Recovery and Empowerment Model for Treating Post-Traumatic Stress Disorder in Women
Trauma Recovery and Empowerment Model (TREM), Usual care - Post-Traumatic Stress Disorder, Mental Disorders
Phase 3CompletedDartmouth-Hitchcock Medical Center3002004-04-012012-07-23
Risperidone Augmentation for PTSD
sertraline and risperidone - Post-Traumatic Stress Disorder
Phase 2 / Phase 3CompletedDuke University802004-04-012014-09-22
BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder
Paroxetine - Post-Traumatic Stress Disorder
Phase 3CompletedGlaxoSmithKline522002-05-012014-03-10

Narrower conditions

Stress Disorders, Post-Traumatic (19)  ·  Anxiety Disorders (4)  ·  Wounds and Injuries (3)  ·  Motor Activity (2)  ·  Depression (1)  ·  Mental Disorders (1)  ·  Self-Injurious Behavior (1)  ·  Substance-Related Disorders (1)  ·  Suicide (1)

Broader conditions

Stress Disorders, Traumatic (19)  ·  Trauma and Stressor Related Disorders (19)  ·  Mental Disorders (18)  ·  Behavior (4)  ·  Behavioral Symptoms (2)  ·  Chemically-Induced Disorders (1)

Interventions

Cognitive Behavioral Therapy (2)  ·  Exercise (2)  ·  Sertraline (2)  ·  Therapeutics (2)  ·  2-cyclohexylidenhydrazo-4-phenyl-thiazole (1)  ·  Control Groups (1)  ·  Cycloserine (1)  ·  Dialectical Behavior Therapy (1)  ·  Levetiracetam (1)  ·  N-Methyl-3,4-methylenedioxyamphetamine (1)  ·  Paroxetine (1)  ·  Quetiapine Fumarate (1)  ·  Risperidone (1)  ·  brexpiprazole (1)  ·  nabiximols (1)

Sponsors

Duke University (2)  ·  University of Konstanz (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  AstraZeneca (1)  ·  Case Western Reserve University (1)  ·  Dartmouth-Hitchcock Medical Center (1)  ·  GlaxoSmithKline (1)  ·  H. Lundbeck A/S (1)  ·  Healing Breakthrough (1)  ·  Jazz Pharmaceuticals (1)  ·  NYU Langone Health (1)  ·  Southern Methodist University (1)  ·  Toronto Metropolitan University (1)  ·  University of Texas at Austin (1)  ·  University of Washington (1)

Countries

United States (12)  ·  Canada (2)  ·  France (2)  ·  Australia (1)  ·  Estonia (1)  ·  Finland (1)  ·  Italy (1)  ·  Martinique (1)  ·  Poland (1)  ·  Republic of the Congo (1)  ·  Serbia (1)  ·  South Africa (1)  ·  Sweden (1)

Top investigators

Jonathan Davidson, M.D. (2)  ·  Barbara Rothbaum, Ph.D. (1)  ·  Candice M. Monson, PhD (1)  ·  Glenn Saxe, MD (1)  ·  Gregory J. McHugo, PhD (1)  ·  Leslie Morland, Psy.D. (1)  ·  Lori A. Zoellner, PhD (1)  ·  Melanie S Harned, PhD (1)  ·  Norah C. Feeny, PhD (1)  ·  Thomas Elbert, Prof. Dr. (1)

Results publications

PMID 25706090, PMID 19439099, PMID 22893167, PMID 23587015, PMID 24717377, PMID 26397721, PMID 29541927, PMID 30336702, PMID 31703570, PMID 32662191, PMID 34672659, PMID 35404227, PMID 39509231

NIH funding

2016 (1), R01MH066348 (1), R01MH068252 (1), R34MH076813 (1), R34MH106598 (1)